39
Participants
Start Date
May 31, 2008
Primary Completion Date
May 31, 2013
Study Completion Date
July 31, 2014
FOLFOX
Oxaliplatin 85/mg/m2 IV infused over two hours followed by Leucovorin 400 mg/m2 IV over 2 hours, followed by 5-FU 400 mg/m2 IV bolus, then 2400 mg/m2 continuous IV infusion over 46-48 hours
bevacizumab
bevacizumab will be used at a dose of 10 mg/kg administered every 2 weeks on day one of FOLFOX chemotherapy
Medical Oncology & Hematology PC, Hamden
Yale University School of Medicine, New Haven
Collaborators (1)
Genentech, Inc.
INDUSTRY
Yale University
OTHER